he intensive care unit (ICU) [1]. Fluid resuscitation is a relevant topic in critical care and the debate on optimal fluid management is evolving. Hydroxyethyl starch (HES) is a colloid used for volume replacement therapy with a controversial history: recently HES-derived products' market authorizations have been reevaluated and more restrictive rules have been released [2-5]. In the United States, the Food and Drug Administration has been requested to withdraw HES-based products by Public Citizen, a nonprofit consumer advocacy organization [2,3]. I
Giordano, G., Pugliese, F., Bilotta, F. (2019). Hydroxyethyl starch and fluid resuscitation. Patient-oriented outcome is the “right way”. JOURNAL OF CRITICAL CARE, 51, 227-227 [10.1016/j.jcrc.2019.02.012].
Hydroxyethyl starch and fluid resuscitation. Patient-oriented outcome is the “right way”
Bilotta F.
2019-01-01
Abstract
he intensive care unit (ICU) [1]. Fluid resuscitation is a relevant topic in critical care and the debate on optimal fluid management is evolving. Hydroxyethyl starch (HES) is a colloid used for volume replacement therapy with a controversial history: recently HES-derived products' market authorizations have been reevaluated and more restrictive rules have been released [2-5]. In the United States, the Food and Drug Administration has been requested to withdraw HES-based products by Public Citizen, a nonprofit consumer advocacy organization [2,3]. I| File | Dimensione | Formato | |
|---|---|---|---|
|
Giordano_Hydroxyethyl-starch_2019.pdf
non disponibili
Licenza:
Copyright dell'editore
Dimensione
86.48 kB
Formato
Adobe PDF
|
86.48 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
